Gene Symbol | CDKN2B |
---|---|
Entrez Gene | 1030 |
Alt Symbol | CDK4I, INK4B, MTS2, P15, TP15, p15INK4b |
Species | Human |
Gene Type | protein-coding |
Description | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
Other Description | CDK inhibitory protein|CDK4B inhibitor|MTS-2|cyclin-dependent kinase 4 inhibitor B|cyclin-dependent kinases 4 and 6 binding protein|multiple tumor suppressor 2|p14-INK4b|p14_CDK inhibitor|p14_INK4B|p15 CDK inhibitor|p15-INK4b|p15_INK4B |
Swissprots | P42772 O15125 Q6FI09 |
Accessions | AAB32712 AAD14049 AAD14186 AAF28397 AAM44859 CAH59951 EAW58596 EAW58597 P42772 AF004819 AAB69989 AF488409 AF488410 AAO49471 AF488411 AF488731 AM392641 CAL37519 AM392962 CAL37840 AM393264 CAL38142 AM393391 CAL38269 BC014469 AAH14469 BC018984 BI560960 CR536529 CAG38766 JQ694046 AFN61601 JQ694047 AFN61602 JQ694048 AFN61603 JX391994 AGC10270 L36844 AAA50282 U17075 AAC50075 NM_004936 NP_004927 NM_078487 NP_511042 |
Function | Interacts strongly with CDK4 and CDK6. Potent inhibitor. Potential effector of TGF-beta induced cell cycle arrest. |
Subcellular Location | Cytoplasm {ECO:0000269|PubMed:9230210}. Note=Also found in the nucleus. |
Tissue Specificity | Isoform 2 is expressed in normal (keratinocytes, fibroblasts) and tumor cell lines. {ECO:0000269|PubMed:9230210}. |
Top Pathways | Cell cycle, TGF-beta signaling pathway, Small cell lung cancer, HTLV-I infection, Viral carcinogenesis |
p15 INK4b peptide - ab109892 from Abcam
|
||||||||||
CDKN2B / p15 INK4b Antibody Blocking Peptide - LS-E1819 from LifeSpan Bioscience
|
||||||||||
CDKN2B / p15 INK4b Antibody Blocking Peptide - LS-E1820 from LifeSpan Bioscience
|
||||||||||
CDKN2B / p15 INK4b Antibody Blocking Peptide - LS-E3007 from LifeSpan Bioscience
|
||||||||||
CDKN2B / p15 INK4b Antibody Blocking Peptide - LS-E3959 from LifeSpan Bioscience
|
||||||||||
CDKN2B / p15 INK4b Antibody Blocking Peptide - LS-E10519 from LifeSpan Bioscience
|
||||||||||
CDKN2B / p15 INK4b Antibody Blocking Peptide - LS-E27798 from LifeSpan Bioscience
|
||||||||||
Recombinant Human p15INK4b/CDKN2B Protein - H00001030-P01 from Novus Biologicals
|
||||||||||
CDKN2B-Antibody-C-term-Blocking-peptide - BP12630b from Abgent, a WuXi AppTec company
|
||||||||||
CDKN2B-Antibody-N-term-Blocking-peptide - BP12629a from Abgent, a WuXi AppTec company
|
||||||||||
CDKN2B-Antibody-C-term-Blocking-peptide - BP14138b from Abgent, a WuXi AppTec company
|
||||||||||
CDKN2B-Antibody-C-term-Blocking-Peptide - BP16165b from Abgent, a WuXi AppTec company
|
||||||||||
CDKN2B Blocking Peptide - 33R-7871 from Fitzgerald
|
||||||||||
p15 Treponema pallidum (His tag) - 80-1369 from Fitzgerald
|
||||||||||
p15 INK4b Peptide - AC21-2859-P from Abcore
|
||||||||||
CDKN2B / p15INK4b - H00001030-P01-10 from Acris Antibodies
|
||||||||||
CDKN2B / p15INK4b - H00001030-P01-25 from Acris Antibodies
|
||||||||||
CDKN2B fusion protein - Ag3557 from Proteintech Group
|
||||||||||
CDKN2B fusion protein - ag16059 from Proteintech Group
|
||||||||||
Recombinant Human CDKN2B, GST-tagged - CDKN2B-11063H from Creative Biomart
|
||||||||||
p15 INK4b Blocking Peptide - CBP1212 from Cohesion Biosciences
|
||||||||||
p15 INK4b (G113) Peptide - BS1267P from Bioworld Technology
|
||||||||||
Recombinant Human Cyclin-dependent kinase 4 inhibitor B(CDKN2B) - CSB-YP005092HU CSB-EP005092HU CSB-BP005092HU CSB-MP005092HU from Cusabio
|
||||||||||
CDKN2B Protein - abx164191 from Abbexa
|
||||||||||
CDKN2B / p15INK4b (transcript variant 2) - TP317024 from Acris Antibodies
|